(Z)-2-(2-methoxy-5-(3,4,5-trimethoxystyryl)phenoxy)ethyl-2-(4-(((diethoxyphosphoryl)(4-methoxyphenyl)methyl)amino)phenyl)acetate

ID: ALA5272906

Chembl Id: CHEMBL5272906

Max Phase: Preclinical

Molecular Formula: C40H48NO11P

Molecular Weight: 749.79

Associated Items:

Names and Identifiers

Canonical SMILES:  CCOP(=O)(OCC)C(Nc1ccc(CC(=O)OCCOc2cc(/C=C\c3cc(OC)c(OC)c(OC)c3)ccc2OC)cc1)c1ccc(OC)cc1

Standard InChI:  InChI=1S/C40H48NO11P/c1-8-51-53(43,52-9-2)40(31-15-19-33(44-3)20-16-31)41-32-17-12-29(13-18-32)27-38(42)50-23-22-49-35-24-28(14-21-34(35)45-4)10-11-30-25-36(46-5)39(48-7)37(26-30)47-6/h10-21,24-26,40-41H,8-9,22-23,27H2,1-7H3/b11-10-

Standard InChI Key:  DMYVJNQAJVBXBM-KHPPLWFESA-N

Alternative Forms

  1. Parent:

    ALA5272906

    ---

Associated Targets(Human)

HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MGC-803 (6426 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
L02 (4864 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-OV-3 (52876 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP2 Tchem Matrix metalloproteinase-2 (6627 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP3 Tchem Matrix metalloproteinase 3 (3433 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP9 Tchem Matrix metalloproteinase 9 (6779 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TUBB4B Tclin Tubulin (5180 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 749.79Molecular Weight (Monoisotopic): 749.2965AlogP: 8.44#Rotatable Bonds: 21
Polar Surface Area: 129.24Molecular Species: NEUTRALHBA: 12HBD: 1
#RO5 Violations: 3HBA (Lipinski): 12HBD (Lipinski): 1#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.64CX Basic pKa: 0.25CX LogP: 6.90CX LogD: 6.90
Aromatic Rings: 4Heavy Atoms: 53QED Weighted: 0.04Np Likeness Score: -0.30

References

1. Huang X, Chen Y, Zhong W, Liu Z, Zhang H, Zhang B, Wang H..  (2022)  Novel combretastatin A-4 derivative containing aminophosphonates as dual inhibitors of tubulin and matrix metalloproteinases for lung cancer treatment.,  244  [PMID:36252396] [10.1016/j.ejmech.2022.114817]

Source